(Q36997144)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17992190%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

review article

1 reference

title

Tumor stress, cell death and the ensuing immune response (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17992190%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17992190%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Grégoire Mignot

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17992190%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Guido Kroemer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17992190%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Bonmort M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17992190%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Zitvogel L

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17992190%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

9 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17992190%20AND%20SRC:MED&resulttype=core&format=json

Cell Death & Differentiation

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17992190%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17992190%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17992190%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

21-28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17992190%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.cdd.4402266

10 January 2020

exact match

0 references

cites work

Inflammation and cancer: back to Virchow?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Decreased tumor surveillance in perforin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Cancer despite immunosurveillance: immunoselection and immunosubversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Cell death modalities: classification and pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Redundant cell death mechanisms as relics and backups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Harnessing the immune system to treat cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

DAMPs, PAMPs and alarmins: all we need to know about danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

How the immune system protects the host from infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Friendly and dangerous signals: is the tissue in control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

CD11chigh dendritic cell ablation impairs lymphopenia-driven proliferation of naive and memory CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Links between innate and cognate tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Natural Killer Cells Activated by MHC Class ILow Targets Prime Dendritic Cells to Induce Protective CD8 T Cell Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Tregs and rethinking cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

A novel dendritic cell subset involved in tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Therapy-induced tumor immunosurveillance involves IFN-producing killer dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Interferon-gamma is produced by another player of innate immune responses: the interferon-producing killer dendritic cell (IKDC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Molecular identification of a danger signal that alerts the immune system to dying cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Extracellular role of HMGB1 in inflammation and sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

HMGB1 is an endogenous immune adjuvant released by necrotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Cytolytic cells induce HMGB1 release from melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Pivotal Advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Infiltrating neutrophils induce allospecific CTL in response to immunization with apoptotic cells via MCP-1 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

TLR3 can directly trigger apoptosis in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Cutting edge: cross-presentation as a mechanism for efficient recruitment of tumor-specific CTL to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Expression of the human PAC1 receptor leads to dose-dependent hydrocephalus-related abnormalities in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

The tumour microenvironment as a target for chemoprevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Know thy neighbor: stromal cells can contribute oncogenic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Putting tumours in context

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Stromal effects on mammary gland development and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

A cytokine-mediated link between innate immunity, inflammation, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

NF-kappaB: linking inflammation and immunity to cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Tumour escape from immune surveillance through dendritic cell inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

A critical role for Stat3 signaling in immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Regulatory T cells under scrutiny

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Is it a DC, is it an NK? No, it's an IKDC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

Cancer; a biological approach. I. The processes of control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

7 January 2021

Inflammation and necrosis promote tumour growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

7 January 2021

Immune response against dying tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

7 January 2021

Immunological aspects of cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

7 January 2021

Partial, but not complete, tumor-debulking surgery promotes protective antitumor memory when combined with chemotherapy and adjuvant immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

7 January 2021

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

7 January 2021

Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-gamma via autocrine IL-12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

7 January 2021

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

7 January 2021

Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

7 January 2021

Antitumor effect of locally produced CD95 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

7 January 2021

Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

7 January 2021

Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

7 January 2021

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402266

7 January 2021